Shortages prompt Metalyse shelf-life extension

heart attack
Hospital pharmacists are being urged to make “appropriate changes” to Metalyse (tenecteplase) packaging to reflect updated expiry dates  Shortages of Boehringer Ingelheim’s Metalyse (tenecteplase) injection products have prompted the Therapeutic Goods Administration (TGA) to extend the shelf life of batches with expiry dates between January 2022 and March 2025, by 12 months.   The move

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Looking ahead
Next World news wrapup: 6 April 2023